Showing results (1831-1840 of 2,268) with videos related to
Sort By:
Pageof 227
Nature Communications|February 22, 2023
Prolonged experimental CD4+ T-cell depletion does not cause disease progression in SIV-infected African green monkeysQuentin Le Hingrat, Paola Sette, Cuiling Xu, et al.Molecular Immunology|June 1, 1995
In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptidesP A Wentworth, E Celis, C Crimi, et al.Nature Communications|April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's diseaseCecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.Immunogenetics|May 17, 2005
The design and implementation of the immune epitope database and analysis resourceBjoern Peters, John Sidney, Phil Bourne, et al.The Journal of Clinical Investigation|December 17, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Antoine Freuchet, Tanner Michaelis, et al.Frontiers in Immunology|December 25, 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, et al.Journal of the Neurological Sciences|December 10, 2022
Unaltered T cell responses to common antigens in individuals with Parkinson's diseaseGregory P Williams, Kaylin Muskat, April Frazier, et al.Journal of Virology|March 22, 2002
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replicationTodd M Allen, Lorenzo Mortara, Bianca R Mothé, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 2023
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunitySharon A Sagan, Zahra Moinfar, Carson E Moseley, et al.NPJ Vaccines|December 22, 2017
Protein nanovaccine confers robust immunity against ToxoplasmaKamal El Bissati, Ying Zhou, Sara Maria Paulillo, et al.Pageof 227